Clinical Trial Update: CBCT Guided Markerless SBRT for Renal Cell Cancer [NA]

View source ↗

Summary

A clinical trial evaluating CBCT-guided markerless SBRT for renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Erasmus Medical Center | Conditions: Renal Cell Carcinoma (RCC) | NA | Status: RECRUITING